Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRF versus PRP injections for androgenetic alopecia
IRCT20251112067973N4Phase 3Not yet recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet rich fibrin and platelet-rich plasma in androgenetic alopecia (AGA) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Change in overall hair density from baseline to the end of the study. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
platelet rich fibrinplatelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20251112067973N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251112067973N4.